Nadeem N. Vaidya, M.D.
NPI- 1578616520

Dr. Nadeem N. Vaidya is a board certified ophthalmologist specializing in the diagnosis, treatment and surgery of the retina and vitreous. He graduated with high honors from Harvard University, and went on to medical school at the Tufts University School of Medicine in Boston, Massachusetts. During his tenure at Tufts, he was elected to the Alpha Omega Alpha Medical Honor Society. He completed his internship in internal medicine at Yale-New Haven Hospital, and completed his residency in ophthalmology at the Mount Sinai School of Medicine. He left New York for a few years to pursue subspecialty training in Medical Retina at the Joslin Diabetes Center of Harvard Medical School, where he pursued several research topics in diabetic retinopathy. Later, he relocated to Memphis, Tennessee, to pursue another fellowship in Vitreoretinal Surgery at the Vitreoretinal Foundation/Eye Specialty Group, one of the oldest fellowships in the country of this type. He returned to New York City, to join MaculaCare, a private practice retina group with Drs. Harvey Lincoff and Daniel Rosberger, two of the preeminent retina surgeons in the world. He then moved to Orange County, California to found Retina Orange County, a solo private practice in Irvine.


  • M.D.
    Tufts University School of Medicine
    Boston, Massachusetts
  • A.B. magna cum laude in Chemistry
    Harvard University
    Cambridge, Massachusetts


Residency & Fellowship

  • Fellowship in Vitreoretinal Surgery
    Vitreoretinal Foundation
    Eye Specialty Group
    Memphis, Tennessee
  • Fellowship in Medical Retina
    Joslin Diabetes Center
    Harvard Medical School
    Boston, Massachusetts
  • Residency in Ophthalmology
    Mount Sinai Medical Center
    Mount Sinai School of Medicine of New York University
    New York, New York
  • Internship in Internal Medicine
    Yale-New Haven Hospital
    Yale University School of Medicine
    New Haven, Connecticut



Fluent in Spanish, Hindi, and Urdu



2011 Patients’ Choice Award
2011 Most Compassionate Physician Award
HealthGrades Recognized Physician
Chief Ophthalmology Resident – Mount Sinai Hospital
Vice-President – Tufts University School of Medicine Chapter – Alpha Omega Alpha Medical Honor Society
Betty Lea Stone Research Fellow – American Cancer Society
Harvard College Research Fellow
Harvard College Scholar
Robert C. Byrd Scholar
National Science Scholar
Edward J. Hopkins Scholar
City of Cambridge Scholar
Dean’s List – Harvard College



  • Phase III, Multicenter, Randomized, Double-masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of RO6867461 in Patients with Diabetic Macular Edema (YOSEMITE) GR40349, Genentech
  • A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator- Controlled Study To Evaluate The Efficacy And Safety Of Faricimab In Patients With Neovascular Age-Related Macular Degeneration (LUCERNE) GR40844, Genentech
  • A Multicenter, Double-Masked, Randomized, Dose- Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration (PANDA 2) KHB-1802,
  • A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab every 4 weeks versus Aflibercept every 4 weeks in Adult Patients with Visual Impairment due to Diabetic Macular Edema (KINGFISHER)
    RTH258B2305, Novartis
  • A 64-week, two-arm, randomized, double-masked, multicenter, phase IIIb study assessing the efficacy and safety of brolucizumab 6 mg compared to aflibercept 2 mg in a treat-to-control regimen in patients with neovascular age-related macular degeneration (TALON)
    , Novartis
  • Diabetic Retinopathy Clinical Research Network
  • Efficacy of a Home Monitoring Tool for use in Wet Age Related Macular Degeneration
  • Efficacy of Intravitreal Sirolimus in Non-Infectious Intermediate and Posterior Uveitis
  • Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration
  • Double-Masked Study of Efficacy and Safety of IVT VEGF Trap-Eye in Subjects With Wet AMD (VIEW 1)
    Regeneron Pharmaceuticals
  • Studied the viability of retinal blood flow measurements as a long-term predictor of diabetic retinopathy progression
    Studied the visual outcome and complication rates after pars plana vitrectomy alone versus combined surgery in diabetic patients
  • Studied genetic variants and molecules that are associated with either progression to or protection from advanced diabetic retinopathy
  • Validated a novel semi-automated digital retinal imaging system (ARIS) against gold-standard Early Treatment Diabetic Retinopathy-protocol 7 standard field stereoscopic fundus photographs for use in ophthalmic clinics and/or clinical trial-grade protocols
  • Studied outcomes of a case series of immune reconstitution uveitis related to Cytomegalovirus retinitis
  • Studied the use of Ovine Hyaluronidase (Vitrase®) in Non-Clearing Vitreous Hemorrhage
  • Studied malignant fibrosarcoma cell lines using Chromophore Assisted Laser Inactivation to selectively knockout surface proteins that are involved in invasiveness and metastasis
  • Studied organometallic catalysis, organic synthesis, and combinatorial chemistry using carpanone derivatives to create a large library of compounds for a biological screen of pharmacological activity
  • Studied Bio-Informatics as applied to genome sequencing





Copyright © Retina Orange County, Inc. 2018 | Credits | Terms of Use | Privacy Policy | Sitemap